OPTIMIZERx Corp
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $7.61
- Today's High:
- $8.15
- Open Price:
- $8.11
- 52W Low:
- $7.24
- 52W High:
- $22.77
- Prev. Close:
- $8.12
- Volume:
- 185159
Company Statistics
- Market Cap.:
- $140.59 million
- Book Value:
- 6.962
- Revenue TTM:
- $61.56 million
- Operating Margin TTM:
- -26.91%
- Gross Profit TTM:
- $38.97 million
- Profit Margin:
- -23.31%
- Return on Assets TTM:
- -7.71%
- Return on Equity TTM:
- -11.19%
Company Profile
OPTIMIZERx Corp had its IPO on 1996-10-22 under the ticker symbol OPRX.
The company operates in the Healthcare sector and Health Information Services industry. OPTIMIZERx Corp has a staff strength of 109 employees.
Stock update
Shares of OPTIMIZERx Corp opened at $8.11 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $7.61 - $8.15, and closed at $7.73.
This is a -4.8% slip from the previous day's closing price.
A total volume of 185,159 shares were traded at the close of the day’s session.
In the last one week, shares of OPTIMIZERx Corp have slipped by -10.84%.
OPTIMIZERx Corp's Key Ratios
OPTIMIZERx Corp has a market cap of $140.59 million, indicating a price to book ratio of 2.4517 and a price to sales ratio of 4.7592.
In the last 12-months OPTIMIZERx Corp’s revenue was $61.56 million with a gross profit of $38.97 million and an EBITDA of $-14661902. The EBITDA ratio measures OPTIMIZERx Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, OPTIMIZERx Corp’s operating margin was -26.91% while its return on assets stood at -7.71% with a return of equity of -11.19%.
In Q2, OPTIMIZERx Corp’s quarterly earnings growth was a negative -66.8% while revenue growth was a negative 1.1%.
OPTIMIZERx Corp’s PE and PEG Ratio
- Forward PE
- 31.1526
- Trailing PE
- 0
- PEG
- 2.0751
Its diluted EPS in the last 12-months stands at $-0.82 per share while it has a forward price to earnings multiple of 31.1526 and a PEG multiple of 2.0751. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into OPTIMIZERx Corp’s profitability.
OPTIMIZERx Corp stock is trading at a EV to sales ratio of 3.7891 and a EV to EBITDA ratio of -27.38. Its price to sales ratio in the trailing 12-months stood at 4.7592.
OPTIMIZERx Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $121.32 million
- Total Liabilities
- $5.51 million
- Operating Cash Flow
- $3.22 million
- Capital Expenditure
- $1.10 million
- Dividend Payout Ratio
- 0%
OPTIMIZERx Corp ended 2024 with $121.32 million in total assets and $0 in total liabilities. Its intangible assets were valued at $121.32 million while shareholder equity stood at $115.82 million.
OPTIMIZERx Corp ended 2024 with $0 in deferred long-term liabilities, $5.51 million in other current liabilities, 18377.00 in common stock, $-57251261.00 in retained earnings and $22.67 million in goodwill. Its cash balance stood at $9.81 million and cash and short-term investments were $62.74 million. The company’s total short-term debt was $14,545 while long-term debt stood at $0.
OPTIMIZERx Corp’s total current assets stands at $85.07 million while long-term investments were $0 and short-term investments were $52.93 million. Its net receivables were $18.28 million compared to accounts payable of $3.54 million and inventory worth $0.
In 2024, OPTIMIZERx Corp's operating cash flow was $3.22 million while its capital expenditure stood at $1.10 million.
Comparatively, OPTIMIZERx Corp paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $7.73
- 52-Week High
- $22.77
- 52-Week Low
- $7.24
- Analyst Target Price
- $21.5
OPTIMIZERx Corp stock is currently trading at $7.73 per share. It touched a 52-week high of $22.77 and a 52-week low of $22.77. Analysts tracking the stock have a 12-month average target price of $21.5.
Its 50-day moving average was $11.69 and 200-day moving average was $14.9 The short ratio stood at 6.68 indicating a short percent outstanding of 0%.
Around 454.8% of the company’s stock are held by insiders while 8389.2% are held by institutions.
Frequently Asked Questions About OPTIMIZERx Corp
Similar Industry Stocks (Health Information Services)
Most Active
Top Gainers
Top Losers
About
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers (HCPs), and patients. Its products and applications include Evidence-Based Physician Engagement solution to assist HCPs in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations; and Point of Care Banner messaging solution to deliver a variety of awareness and messaging within the clinical workflow. The company also offers Social Network Banner Messaging solution to deliver banner messaging to HCPs within their social network apps; Institutional Account-based Banner Messaging solution that provides its clients access to delivering banner messaging online and on the intranets of targeted health system accounts; and Financial Messaging solution, which provides prescribers visibility to branded copay offers and other patient support programs directly within their electronic health record and/or e-Prescribe systems. In addition, it provides Patient Engagement, a technology solution that provides digital messaging services through its cloud-based Mobile Health Messenger platform; HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance; and Therapy Initiation Workflow, a group of digital solutions that focuses on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was founded in 2006 and is headquartered in Rochester, Michigan.